ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「不安障害の最新治療エビデンス:SSRI・SNRI・認知行動療法の効果と限界を徹底解説」の検索結果

21,804 件中 10 件を表示 (4563 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
(anxiety disorders[MeSH] OR anxiety) AND (selective serotonin reuptake inhibitors[MeSH] OR SSRI OR serotonin norepinephrine reuptake inhibitors[MeSH] OR SNRI OR cognitive behavioral therapy[MeSH] OR CBT) AND (treatment outcome[MeSH] OR efficacy OR effectiveness OR limitations)

💡 不安障害とSSRI/SNRI/CBTの治療効果と限界に関する包括的検索。MeSH用語と略語を組み合わせて網羅性を確保しました。

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Anxiety Disorders: A Review.

    Kristin L Szuhany, Naomi M Simon · JAMA · 2022

    Anxiety disorders have a lifetime prevalence of approximately 34% in the US, are often chronic, and significantly impair quality of life and functioning. Anxiety disorders are characterized by symptoms that include worry, social and performance fears, unexpected and/or triggered panic attacks, anticipatory anxiety, and avoidance behaviors. Generalized anxiety disorder (6.2% lifetime prevalence), s…

    📄 PubMed で読む (PMID: 36573969)
  • Treatment of anxiety disorders.

    Borwin Bandelow, Sophie Michaelis, Dirk Wedekind 他 · Dialogues in clinical neuroscience · 2017

    Anxiety disorders (generalized anxiety disorder, panic disorder/agoraphobia, social anxiety disorder, and others) are the most prevalent psychiatric disorders, and are associated with a high burden of illness. Anxiety disorders are often underrecognized and undertreated in primary care. Treatment is indicated when a patient shows marked distress or suffers from complications resulting from the dis…

    📄 PubMed で読む (PMID: 28867934)
  • Anxiety.

    Michelle G Craske, Murray B Stein · Lancet (London, England) · 2016

    Anxiety disorders (separation anxiety disorder, selective mutism, specific phobias, social anxiety disorder, panic disorder, agoraphobia, and generalised anxiety disorder) are common and disabling conditions that mostly begin during childhood, adolescence, and early adulthood. They differ from developmentally normative or stress-induced transient anxiety by being marked (ie, out of proportion to t…

    📄 PubMed で読む (PMID: 27349358)
  • Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders.

    Heather J Walter, Oscar G Bukstein, A Reese Abright 他 · Journal of the American Academy of Child and Adolescent Psychiatry · 2020

    Anxiety disorders are among the most common psychiatric disorders in children and adolescents. As reviewed in this guideline, both cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitor (SSRI) medication have considerable empirical support as safe and effective short-term treatments for anxiety in children and adolescents. Serotonin norepinephrine reuptake inhibitor (SNRI) m…

    📄 PubMed で読む (PMID: 32439401)
  • Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety.

    Jeffrey R Strawn, Jeffrey A Mills, Vikram Suresh 他 · Journal of affective disorders · 2022

    Treatment studies of children and adolescents with internalizing disorders suggest that the combination of a selective serotonin reuptake inhibitor (SSRI) and cognitive behavioral therapy (CBT) consistently produces greater improvement than either treatment alone. We sought to determine how response to combined treatment varies across disorders (anxiety versus depression), and by specific patient …

    📄 PubMed で読む (PMID: 34728290)
  • Pharmacotherapy for Anxiety Disorders.

    Kerry B O'Leary, Jeffrey S Khan · The Psychiatric clinics of North America · 2024

    Anxiety disorders are the most common psychiatric illness and include disorders such as generalized anxiety disorder (GAD), panic disorder (PD), and social anxiety disorder (SAD). Psychotherapy and pharmacotherapy are both effective treatments for anxiety disorders, with efficacy between 60% and 85%. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are first…

    📄 PubMed で読む (PMID: 39505448)
  • Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

    Antonio Del Casale, Serena Sorice, Alessio Padovano 他 · Current neuropharmacology · 2019

    Obsessive-compulsive disorder (OCD) is associated with affective and cognitive symptoms causing personal distress and reduced global functioning. These have considerable societal costs due to healthcare service utilization. Our aim was to assess the efficacy of pharmacological interventions in OCD and clinical guidelines, providing a comprehensive overview of this field. We searched the PubMed dat…

    📄 PubMed で読む (PMID: 30101713)
  • World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.

    Borwin Bandelow, Christer Allgulander, David S Baldwin 他 · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2023

    This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (published in 2002, revised in 2008). A consensus panel of 33 international experts representing 22 countries developed recommendations based on efficacy and acceptability of…

    📄 PubMed で読む (PMID: 35900161)
  • Generalized Anxiety Disorder.

    Jeremy DeMartini, Gayatri Patel, Tonya L Fancher 他 · Annals of internal medicine · 2019

    Generalized anxiety disorder (GAD) is a common and disabling illness that is often underdiagnosed and undertreated. Patients with GAD are at increased risk for suicide as well as cardiovascular-related events and death. Most patients can be diagnosed and managed by primary care physicians. Symptoms include chronic, pervasive anxiety and worry accompanied by nonspecific physical and psychological s…

    📄 PubMed で読む (PMID: 30934083)
  • Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

    John T Walkup, Anne Marie Albano, John Piacentini 他 · The New England journal of medicine · 2008

    Anxiety disorders are common psychiatric conditions affecting children and adolescents. Although cognitive behavioral therapy and selective serotonin-reuptake inhibitors have shown efficacy in treating these disorders, little is known about their relative or combined efficacy. In this randomized, controlled trial, we assigned 488 children between the ages of 7 and 17 years who had a primary diagno…

    📄 PubMed で読む (PMID: 18974308)